NCT04056013 is a NA clinical trial of Vicryl Rapide absorbable suture in Traumatic Lacerations, sponsored by University of California, San Francisco.

Who is sponsoring NCT04056013?

NCT04056013 is sponsored by University of California, San Francisco.

What drugs are being tested in NCT04056013?

Interventions in NCT04056013: Vicryl Rapide absorbable suture.

What condition does NCT04056013 study?

NCT04056013 studies Traumatic Lacerations.

Is NCT04056013 still recruiting?

NCT04056013 is currently recruiting now. Last updated 28 February 2025.

Last reviewed 2025-02-28 · How we verify

NCT04056013

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vicryl Rapide Versus Nonabsorbable Suture

Recruiting now NA Last updated 28 February 2025

What this trial tests

NA trial testing Vicryl Rapide absorbable suture in Traumatic Lacerations in 96 participants. Currently enrolling.

Timeline

26 September 2019

Primary endpoint
1 September 2028

31 January 2029

Quick facts

Lead sponsor	University of California, San Francisco
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	96
Start date	26 September 2019
Primary completion	1 September 2028
Estimated completion	31 January 2029
Sites	2 locations across United States

Drugs / interventions tested

Vicryl Rapide absorbable suture

Conditions studied

Traumatic Lacerations — all drugs for Traumatic Lacerations →

Sponsor

University of California, San Francisco

Who can join

18 and older, any sex, with Traumatic Lacerations. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This will be a prospective, randomized controlled trial assessing noninferiority of Vicryl Rapide compared to nonabsorbable suture. The study will be conducted in the Community Regional Medical Center emergency department (ED). The aim of this study, then, is to prospectively determine if 3-month cosmesis for traumatic laceration repair of trunk/extremity lacerations in adult patients with Vicryl Rapide is noninferior to nonabsorbable suture.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of California, San Francisco trials

Trials by the same sponsor.

NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04056013 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
Last refreshed: 28 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04056013.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing